相关实验视频

Updated: Jul 14, 2025

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

对结肠直肠癌最近免疫治疗的免疫学评估

Subhadeep Das¹, Diptikanta Acharya¹

¹Department of Biotechnology, GIET University, Gunupur, India.

Immunological investigations

|October 9, 2023

概括

免疫疗法为传统结直肠癌 (CRC) 治疗提供了一个有希望的替代方案,显示出增强的抗瘤免疫反应. 本综述探讨了最近的免疫疗法进展和组合策略,以改善CRC患者的临床结果.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症研究癌症研究

背景情况:

结肠直肠癌 (CRC) 由于发病率和死亡率的上升,对全球健康构成了重大挑战.
传统的CRC疗法往往由于细胞毒性和缺乏特异性而不足.
迫切需要新的治疗策略来改善不同CRC患者群体的治疗结果.

研究的目的:

审查最近在结直肠癌 (CRC) 免疫治疗方面的进展.
从里程碑式的临床研究 (2019-2023) 中分析抗瘤免疫反应.
突出组合免疫疗法方法及其克服免疫抑制的潜力.

主要方法:

关于CRC免疫疗法的综合文献综述.
专注于2019年至2023年间发表的临床研究.
综合疗法中协同效应和免疫抑制调节的分析.

主要成果:

免疫疗法已经成为癌症治疗的转型方法,包括CRC.
了解癌症免疫循环和瘤微环境是提高免疫治疗疗效的关键.
组合策略在协同增强对CRC的免疫反应方面显示出希望.

结论:

最近的免疫疗法研究为改善CRC治疗提供了显著的潜力.
进一步研究组合疗法对于克服治疗局限性至关重要.
将当前的知识转化为合理的临床试验设计,可以在CRC中产生更有效的抗瘤免疫反应.

关键词:

抗瘤免疫反应是一种免疫反应.临床试验是指临床试验中的临床试验.结肠直肠癌是什么意思免疫疗法免疫疗法

更多相关视频

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Published on: June 2, 2023

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...